about
Stromal Targets for Fluorescent-Guided Oncologic SurgeryQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingValidation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.Nanobody: the "magic bullet" for molecular imaging?Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.Biological evaluation of 131I- and CF750-labeled Dmab(scFv)-Fc antibodies for xenograft imaging of CD25-positive tumors.Direct validation of aptamers as powerful tools to image solid tumorPET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61BDiscovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imagingGlypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imagingAntibody-derived in vivo imaging of tau pathology.CF750-A33scFv-Fc-Based Optical Imaging of Subcutaneous and Orthotopic Xenografts of GPA33-Positive Colorectal Cancer in Mice.In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment.Targeting tumor hypoxia with 2-nitroimidazole-indocyanine green dye conjugates.Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression.Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyEngineered antibodies for molecular imaging of cancer.Dye-doped silica nanoparticles as luminescent organized systems for nanomedicine.Antibody-based imaging strategies for cancer.In vivo optical imaging of MMP2 immuno protein antibody: tumor uptake is associated with MMP2 activityEffect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugatesMolecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.Deglycosylation of mAb by EndoS for improved molecular imaging.Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates.Novel bifunctional single-chain variable antibody fragments to enhance virolysis by complement: generation and proof-of-concept.Generation and evaluation of antibody agents for molecular imaging of CD44v6-expressing cancers.Fluorescence Imaging of Inflammation in Live Animals.Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASHGeneration and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging
P2860
Q26774497-7596FE8A-B35E-472B-961B-D3B3B89377CEQ27023605-F35ED4AD-6754-492A-8438-C9D1558CEF2DQ30413694-51CD40F9-F322-4676-8228-B6F7C20FFB39Q30414100-BC382BF9-DCCE-46AF-B8B5-3374DF462082Q30442626-41129C85-F0C9-492B-9F84-E1E729EE4145Q30620931-A65FC708-1FFE-42F3-B68F-7E2C3C99C88FQ33597766-968222FE-652C-456D-83F2-EFA02F5ABEDAQ33632641-0F61F1AD-F573-4039-A31E-E0D37D6E523EQ33728010-FA472BF5-E328-4114-BB36-B6CF704DB5D8Q33921086-07393A09-5EFE-4BB0-BCB0-4878C9AF96E2Q33974776-04B0915E-752E-410D-B198-6DA4A1BED25FQ34662001-F9D20C98-99EA-4B9D-8DD8-A6D871079A3EQ34664345-0BF87ADF-0B76-4CCA-A88F-93E46D100057Q35680685-5571DFB6-B838-4F1C-A086-39B0F31989FEQ36094945-C162389D-3030-44EC-9C76-7DCC2B0261A8Q36136306-EE396665-74E3-4C6A-919E-DC9B408DD8FEQ36518309-B001EF1B-7074-40FC-9C9F-A34D6A3A87EAQ36724890-92F61B8A-1F64-4337-8F63-C111A93C107AQ36923843-E58741C3-E7A3-4E57-A0C7-54B8F757D6F0Q37563673-D30CB89C-8D29-4F15-9A4B-5B54937FB5D1Q37689802-4BBB95B2-D9A1-487A-8B10-DBD82977BD6BQ38148881-A939D4A5-DCBC-44B2-9A92-00CFC1D94D6CQ38197082-CA16138B-66D7-4284-89EB-4168AA3C18EFQ38218986-178981E8-7F1F-4AFD-A2B1-C5F32E2BACE1Q38672056-7ACDBC55-D69A-4B50-BA77-327445DEE979Q38756124-F18C4247-37A9-48EF-8182-4BC4FFE4429CQ38880847-DB85B512-CD1A-41C5-BDDB-B260F9FFE33AQ38964828-B951E691-7CB4-4A85-A14D-5686DA3BD8DCQ41553931-6D77B418-B914-47A8-8623-D57554EE66F3Q41763928-E8A02EFF-0D73-47DA-A7E1-CCFD98A54D3EQ42371513-F4B98D1E-5E9E-4E99-99B8-B3AFC04167FEQ46534884-4A1FCB86-664C-46C9-B3CA-E69BA12964E0Q57210121-219AE182-363A-4C6B-AE58-4494E26780B1Q58579050-43EB00FC-076D-41A5-83B8-3069FAF7A130
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Recent trends in antibody-based oncologic imaging
@ast
Recent trends in antibody-based oncologic imaging
@en
type
label
Recent trends in antibody-based oncologic imaging
@ast
Recent trends in antibody-based oncologic imaging
@en
prefLabel
Recent trends in antibody-based oncologic imaging
@ast
Recent trends in antibody-based oncologic imaging
@en
P2093
P2860
P1433
P1476
Recent trends in antibody-based oncologic imaging
@en
P2093
Ganesh Venktaraman
Maneesh Jain
Pradeep K Garg
Shantibhusan Senapati
Sukhwinder Kaur
Surinder K Batra
P2860
P304
P356
10.1016/J.CANLET.2011.10.017
P407
P577
2011-10-20T00:00:00Z